Duration of untreated psychosis and negative symptoms - A systematic review and meta-analysis of individual patient data

Schizophrenia Research

Volumn 142, Issue 1-3, 2012, Pages 12-19

  Boonstra, Nynke ^a,b,c   Klaassen, Rianne ^d   Sytema, Sjoerd ^b   Marshall, Max ^e   De Haan, Lieuwe ^f   Wunderink, Lex ^a,b   Wiersma, Durk ^b  

^a Department of Education and Research ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c NHL University for Applied Sciences   (Netherlands)

^d Rivierduinen   (Netherlands)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

First episode psychosis; Negative symptoms; Schizophrenia; Treatment delay

Indexed keywords

CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FOLLOW UP; HUMAN; NEGATIVE SYNDROME; ONSET AGE; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOTHERAPY; REVIEW; SYSTEMATIC REVIEW; THERAPY DELAY; THERAPY EFFECT;

AGE OF ONSET; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PSYCHOTIC DISORDERS;

EID: 84869863131     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.08.017     Document Type: Review

References (60)

1. Addington J., Addington D. Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia. J. Psychiatry Neurosci. 1993, 18(1):18-23.
2. Addington J., Van Mastrigt S., Addington D. Duration of untreated psychosis: impact on 2-year outcome. Psychol. Med. 2004, 34(2):277-284.
3. Andreasen N.C. The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br. J. Psychiatry Suppl. 1989, 7:49-58.
4. Barnes T.R., Hutton S.B., Chapman M.J., Mutsatsa S., Puri B.K., Joyce E.M. West London first-episode study of schizophrenia. Clinical correlates of duration of untreated psychosis. Br. J. Psychiatry 2000, 177:207-211.
5. Birchwood M. Early intervention and sustaining the management of vulnerability. Aust. N. Z. J. Psychiatry 2000, 34(Suppl.):S181-S184.
6. Black K., Peters L., Rui Q., Milliken H., Whitehorn D., Kopala L.C. Duration of untreated psychosis predicts treatment outcome in an early psychosis program. Schizophr. Res. 2001, 47(2-3):215-222.
7. Blanchard J.J., Horan W.P., Collins L.M. Examining the latent structure of negative symptoms: is there a distinct subtype of negative symptom schizophrenia?. Schizophr. Res. 2005, 77(2-3):151-165.
8. Borenstein M., Hedges L.V., Higgins J.P.T., Rowlands R.P. Introduction to Meta-Analysis 2009, John Whiley & Sons Ltd., The Atrium, Southern Gate, Chisterer, West Sussex, United Kingdom.
9. Buckley P.F., Stahl S.M. Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac?. Acta Psychiatr. Scand. 2007, 115(2):93-100.
10. Castelein S., Bruggeman R., van Busschbach J.T., van Der G.M., Stant A.D., Knegtering H., et al. The effectiveness of peer support groups in psychosis: a randomized controlled trial. Acta Psychiatr. Scand. 2008, 118(1):64-72.
11. Chen E.Y., Hui C.L., Chan R.C., Dunn E.L., Miao M.Y., Yeung W.S., et al. A 3-year prospective study of neurological soft signs in first-episode schizophrenia. Schizophr. Res. 2005, 75(1):45-54.
12. Clarke M., Whitty P., Browne S., McTigue O., Kamali M., Gervin M., et al. Untreated illness and outcome of psychosis. Br. J. Psychiatry 2006, 189:235-240.
13. Craig T.J., Bromet E.J., Fennig S., Tanenberg-Karant M., Lavelle J., Galambos N. Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series?. Am. J. Psychiatry 2000, 157(1):60-66.
14. Crespo-Facorro B., Roiz-Santianez R., Pelayo-Teran J.M., Gonzalez-Blanch C., Perez-Iglesias R., Gutierrez A., et al. Caudate nucleus volume and its clinical and cognitive correlations in first episode schizophrenia. Schizophr. Res. 2007, 91(1-3):87-96.
15. Cullberg J., Levander S., Holmqvist R., Mattsson M., Wieselgren I.M. One-year outcome in first episode psychosis patients in the Swedish Parachute project. Acta Psychiatr. Scand. 2002, 106(4):276-285.
16. de Haan L., van Der G.M., Wolthaus J. Duration of untreated psychosis and the long-term course of schizophrenia. Eur. Psychiatry 2000, 15(4):264-267.
17. Drake R.J., Haley C.J., Akhtar S., Lewis S.W. Causes and consequences of duration of untreated psychosis in schizophrenia. Br. J. Psychiatry 2000, 177:511-515.
18. Gold C., Solli H.P., Kruger V., Lie S.A. Dose-response relationship in music therapy for people with serious mental disorders: systematic review and meta-analysis. Clin. Psychol. Rev. 2009, 29(3):193-207.
19. Gorna K., Jaracz K., Rybakowski F., Rybakowski J. Determinants of objective and subjective quality of life in first-time-admission schizophrenic patients in Poland: a longitudinal study. Qual. Life Res. 2008, 17(2):237-247.
20. Harris M.G., Henry L.P., Harrigan S.M., Purcell R., Schwartz O.S., Farrelly S.E., et al. The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophr. Res. 2005, 79(1):85-93.
21. Herbener E.S., Harrow M. Longitudinal assessment of negative symptoms in schizophrenia/schizoaffective patients, other psychotic patients, and depressed patients. Schizophr. Bull. 2001, 27(3):527-537.
22. Heydebrand G., Weiser M., Rabinowitz J., Hoff A.L., DeLisi L.E., Csernansky J.G. Correlates of cognitive deficits in first episode schizophrenia. Schizophr. Res. 2004, 68(1):1-9.
23. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327(7414):557-560.
24. Ho B.C., Andreasen N.C., Flaum M., Nopoulos P., Miller D. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am. J. Psychiatry 2000, 157(5):808-815.
25. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
26. Kirkpatrick B., Fenton W.S., Carpenter W.T., Marder S.R. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr. Bull. 2006, 32(2):214-219.
27. Larsen T.K., Moe L.C., Vibe-Hansen L., Johannessen J.O. Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophr. Res. 2000, 45(1-2):1-9.
28. Leucht S., Heres S., Kissling W., Davis J.M. Evidence-based pharmacotherapy of schizophrenia. Int. J. Neuropsychopharmacol. 2011, 1-16.
29. Makinen J., Miettunen J., Isohanni M., Koponen H. Negative symptoms in schizophrenia: a review. Nord. J. Psychiatry 2008, 62(5):334-341.
30. Malla A.K., Takhar J.J., Norman R.M., Manchanda R., Cortese L., Haricharan R., et al. Negative symptoms in first episode non-affective psychosis. Acta Psychiatr. Scand. 2002, 105(6):431-439.
31. Malla A., Norman R., McLean T., Scholten D., Townsend L. A Canadian programme for early intervention in non-affective psychotic disorders. Aust. N. Z. J. Psychiatry 2003, 37(4):407-413.
32. Malla A.K., Norman R.M., Takhar J., Manchanda R., Townsend L., Scholten D., et al. Can patients at risk for persistent negative symptoms be identified during their first episode of psychosis?. J. Nerv. Ment. Dis. 2004, 192(7):455-463.
33. Malla A., Schmitz N., Norman R., Archie S., Windell D., Roy P., et al. A multisite Canadian study of outcome of first-episode psychosis treated in publicly funded early intervention services. Can. J. Psychiatry 2007, 52(9):563-571.
34. Manchanda R., Norman R., Malla A., Harricharan R., Takhar J., Northcott S. EEG abnormalities and two year outcome in first episode psychosis. Acta Psychiatr. Scand. 2005, 111(3):208-213.
35. Marshall M., Lewis S., Lockwood A., Drake R., Jones P., Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch. Gen. Psychiatry 2005, 62(9):975-983.
36. Melle I., Larsen T.K., Haahr U., Friis S., Johannessen J.O., Opjordsmoen S., et al. Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch. Gen. Psychiatry 2004, 61(2):143-150.
37. Melle I., Haahr U., Friis S., Hustoft K., Johannessen J.O., Larsen T.K., et al. Reducing the duration of untreated first-episode psychosis - effects on baseline social functioning and quality of life. Acta Psychiatr. Scand. 2005, 112(6):469-473.
38. Melle I., Larsen T.K., Haahr U., Friis S., Johannesen J.O., Opjordsmoen S., et al. Prevention of negative symptom psychopathologies in first-episode schizophrenia: two-year effects of reducing the duration of untreated psychosis. Arch. Gen. Psychiatry 2008, 65(6):634-640.
39. Montague L.R., Tantam D., Newby D., Thomas P., Ring N. The incidence of negative symptoms in early schizophrenia, mania and other psychoses. Acta Psychiatr. Scand. 1989, 79(6):613-618.
40. NICE The Nice Guideline on Core Interventions in the Treatment and Management of Schizoprenia in Adults in Primary and Secondary Care, updated edition. The British Psychological Society and The Royal College of Psychiatrists 2010.
41. Oosthuizen P., Emsley R.A., Keyter N., Niehaus D.J., Koen L. Duration of untreated psychosis and outcome in first-episode psychosis. Perspective from a developing country. Acta Psychiatr. Scand. 2005, 111(3):214-219.
42. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychol. Rep. 1962, 10:799-812.
43. Perkins D.O. Review: longer duration of untreated psychosis is associated with worse outcome in people with first episode psychosis. Evid. Based Ment. Health 2006, 9(2):36.
44. Petersen L., Jeppesen P., Thorup A., Abel M.B., Ohlenschlaeger J., Christensen T.O., et al. A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. BMJ 2005, 331(7517):602.
45. Petersen L., Thorup A., Oqhlenschlaeger J., Christensen T.O., Jeppesen P., Krarup G., et al. Predictors of remission and recovery in a first-episode schizophrenia spectrum disorder sample: 2-year follow-up of the OPUS trial. Can. J. Psychiatry 2008, 53(10):660-670.
46. Pogue-Geile M.F., Harrow M. Negative symptoms in schizophrenia: their longitudinal course and prognostic importance. Schizophr. Bull. 1985, 11(3):427-439.
47. Rohricht F., Priebe S. Effect of body-oriented psychological therapy on negative symptoms in schizophrenia: a randomized controlled trial. Psychol. Med. 2006, 36(5):669-678.
48. Schmitz N., Malla A., Norman R., Archie S., Zipursky R. Inconsistency in the relationship between duration of untreated psychosis (DUP) and negative symptoms: sorting out the problem of heterogeneity. Schizophr. Res. 2007, 93(1-3):152-159.
49. Sim K., Swapna V., Mythily S., Mahendran R., Kua E.H., McGorry P., et al. Psychiatric comorbidity in first episode psychosis: the Early Psychosis Intervention Program (EPIP) experience. Acta Psychiatr. Scand. 2004, 109(1):23-29.
50. Snijders T.A.B., BRJ Multi-Level Analysis: An Introduction to Basis and Advances Multilevel Modeling 1999, SAGE Publication, London.
51. StataCorp. Stata Statistical Software: Release 11 2009, College Station, StataCorp LP, Texas.
52. Stewart L.A., Parmar M.K. Meta-analysis of the literature or of individual patient data: is there a difference?. Lancet 1993, 341(8842):418-422.
53. Stewart L.A., Tierney J.F. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval. Health Prof. 2002, 25(1):76-97.
54. Subramaniam M., Pek E., Verma S., Chan Y.H., Chong S.A. Diagnostic stability 2 years after treatment initiation in the early psychosis intervention programme in Singapore. Aust. N. Z. J. Psychiatry 2007, 41(6):495-500.
55. Ucok A., Polat A., Cakir S., Genc A. One year outcome in first episode schizophrenia. Predictors of relapse. Eur. Arch. Psychiatry Clin. Neurosci. 2006, 256(1):37-43.
56. Verdoux H., Liraud F., Bergey C., Assens F., Abalan F., van Os J. Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-admitted patients. Schizophr. Res. 2001, 49(3):231-241.
57. Vyas N.S., Hadjulis M., Vourdas A., Byrne P., Frangou S. The Maudsley early onset schizophrenia study. Predictors of psychosocial outcome at 4-year follow-up. Eur. Child Adolesc. Psychiatry 2007, 16(7):465-470.
58. Wade D., Harrigan S., Edwards J., Burgess P.M., Whelan G., McGorry P.D. Patterns and predictors of substance use disorders and daily tobacco use in first-episode psychosis. Aust. N. Z. J. Psychiatry 2005, 39(10):892-898.
59. Wunderink A., Nienhuis F.J., Sytema S., Wiersma D. Treatment delay and response rate in first episode psychosis. Acta Psychiatr. Scand. 2006, 113(4):332-339.
60. Yamazawa R., Nemoto T., Kobayashi H., Chino B., Kashima H., Mizuno M. Association between duration of untreated psychosis, premorbid functioning, and cognitive performance and the outcome of first-episode schizophrenia in Japanese patients: prospective study. Aust. N. Z. J. Psychiatry 2008, 42(2):159-165.